Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BVMF/T1CH34 stock hub

BVMF/T1CH34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/T1CH34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

37.1B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/T1CH34

In the news

Latest news · BVMF/T1CH34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E23.8

P25 11.3P50 14.6P75 19.6

Trailing P/E64.9

P25 15.2P50 21.5P75 27.3

ROE5.3

P25 5.3P50 12.3P75 22.5

ROIC10.7

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/T1CH34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

226

Groups with data

Currency

USD

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	3,100
Employees Change	0%
Employees Change Percent	0
Enterprise value	BRL 37.5B
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	BRL 37.1B
Price	BRL 8.03
Price currency	BRL
Rev Per Employee	2,037,570.33x
Sector	Healthcare
Sic	2836
Symbol	bvmf/T1CH34
Website	https://www.bio-techne.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.54%
EV Earnings	65.57x
EV/EBIT	24.63x
EV/EBITDA	19.61x
EV/FCF	26.63x
EV/Sales	6.32x
FCF yield	3.79%
Forward P/E	23.81x
P/B ratio	3.41x
P/E ratio	64.92x
P/S ratio	5.87x
PE Ratio10 Y	64.44x
PE Ratio3 Y	75.05x
PE Ratio5 Y	74.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	25.58%
EBITDA Margin	30.23%
FCF margin	22.27%
Gross margin	66.4%
Gross Profit	BRL 4.2B
Gross Profit Growth	-0.18%
Gross Profit Growth Q	-2.63%
Gross Profit Growth3 Y	1.62%
Gross Profit Growth5 Y	7.1%
Net Income	BRL 571.2M
Net Income Growth	-16.79%
Net Income Growth Q	125.99%
Net Income Growth3 Y	-26.09%
Net Income Growth5 Y	-9.87%
Pretax Margin	12.15%
Profit Margin	9.05%
Profit Per Employee	BRL 184,267
ROA	7.45
Roa5y	6.84
ROCE	12.92
ROE	5.34
Roe5y	10.62
ROIC	10.72
Roic5y	11.68

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-11.61%
Cagr3y	-15.93%
Cagr5y	-14.99%
Div CAGR3	2.29%
EPS Growth	-15.36
EPS Growth Q	128.6
EPS Growth3 Y	-25.49
EPS Growth5 Y	-9.56
FCF Growth	22.13%
FCF Growth Q	150.27%
FCF Growth3 Y	5.02%
FCF Growth5 Y	3.72%
OCF Growth	11.33%
OCF Growth Q	110.75%
OCF Growth10 Y	7.38%
OCF Growth3 Y	2.51%
OCF Growth5 Y	1.41%
Revenue Growth	0.17x
Revenue Growth Q	-1.51x
Revenue Growth3 Y	2.52x
Revenue Growth5 Y	7.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.47
Assets	BRL 13.3B
Cash	BRL 1.1B
Current Assets	BRL 3.4B
Current Liabilities	BRL 753.2M
Debt	BRL 1.5B
Debt EBITDA	BRL 0.75
Debt Equity	BRL 0.14
Debt FCF	BRL 1.08
Equity	BRL 10.9B
Interest Coverage	31.98
Liabilities	BRL 2.4B
Long Term Assets	BRL 9.9B
Long Term Liabilities	BRL 1.7B
Net Cash	BRL -397.6M
Net Cash By Market Cap	BRL -1.07
Net Debt EBITDA	BRL 0.21
Net Debt Equity	BRL 0.04
Net Debt FCF	BRL 0.28
Tangible Book Value	BRL 4.1B
Tangible Book Value Per Share	BRL 26.28
WACC	11.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.49
Inventory Turnover	2.07
Net Working Capital	BRL 1.7B
Quick ratio	2.8
Working Capital	BRL 2.8B
Working Capital Turnover	BRL 12.72

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.27%
Dividend Growth	-2.97%
Dividend Growth Years	2%
Dividend per share	BRL 0.04
Dividend Years	7
Dividend Yield	0.49%
Ex Div Date	2026-02-12
Last Dividend	BRL 0.01
Payout Frequency	Quarterly
Payout Ratio	45.47%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-11.6%
200-day SMA	11.36
3Y total return	-40.58%
50-day SMA	10.04
50-day SMA vs 200-day SMA	50under200
5Y total return	-55.6%
All Time High	23.75
All Time High Change	-66.19%
All Time High Date	2021-09-24
All Time Low	5.01
All Time Low Change	60.28%
All Time Low Date	2024-03-18
ATR	0.42
Beta	1.41
Ch YTD	-25.44
High	8.24
High52	12.57
High52 Date	2026-01-15
High52ch	-36.12%
Low	7.96
Low52	7.53
Low52 Date	2026-05-06
Low52ch	6.64%
Ma50ch	-20.04%
Price vs 200-day SMA	-29.3%
RSI	38.21
RSI Monthly	39.12
RSI Weekly	35.66
Sharpe ratio	0.17x
Sortino ratio	0.35
Total Return	2.76%
Tr YTD	-25.38
Tr1m	-11.95%
Tr1w	3.61%
Tr3m	-32.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 1.6B
Operating Income Growth	40.06
Operating Income Growth Q	71.92
Operating Income Growth3 Y	6.61
Operating Income Growth5 Y	8.55
Operating margin	25.58

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	154,661,627%
Net Borrowing	-638,846,000
Shares Insiders	1.14%
Shares Institutions	116.79%
Shares Qo Q	0.26%
Shares Yo Y	-2.27%
Short Ratio	5.66

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 1.2B
Average Volume	43.65x
Bv Per Share	69.5
CAPEX	BRL -131.8M
Ch1m	-11.95
Ch1w	3.61
Ch1y	-11.95
Ch3m	-33.03
Ch3y	-41.17
Ch5y	-56.24
Ch6m	-21.43
Change	3.61%
Change From Open	-2.55
Close	7.75
Days Gap	6.32
Depreciation Amortization	276,811,971.8
Dollar Volume	2,834.6
Earnings Date	2026-08-05
EBIT	BRL 1.6B
EBITDA	BRL 1.9B
EPS	BRL 3.62
F Score	7
FCF	BRL 1.4B
FCF EV Yield	3.75x
Financing CF	-1,180,847,438
Fiscal Year End	June
Founded	1,976
Graham Number	2.56047
Graham Upside	-68.11
Income Tax	BRL 196M
Investing CF	-55,959,809
Is Primary Listing	0
Last Earnings Date	2026-02-04
Last Report Date	2026-03-31
Last Split Date	2022-11-30
Last Split Type	Forward
Lynch Fair Value	BRL 0.62
Lynch Upside	-92.3
Ma150	11.41
Ma150ch	-29.64%
Ma20	9.05
Ma20ch	-11.25%
Net CF	360,731,317
Next Earnings Date	2026-08-05
Open	8.24
P FCF Ratio	26.37
P OCF Ratio	24.11
Payment Date	2026-03-05
Position In Range	25
Ppne	1,480,677,945.2
Price Date	2026-05-08
Price EBITDA	BRL 19.42
Ptbv Ratio	9.02
Relative Volume	8.09x
Revenue	6,316,468,014x
SBC By Revenue	3.36x
Share Based Comp	212,242,457
Tax By Revenue	3.1x
Tax Rate	25.54%
Tr6m	-21.29%
Volume	353
Z Score	13.08

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/T1CH34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$0.04 annual per share

Payout ratio

+45.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

2 consecutive years of growth

Total shareholder yield

+2.8%

Next ex-dividend date: 2026-02-12

Performance

BVMF/T1CH34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/T1CH34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+116.8%

Share of float held by funds and institutions

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVMF/T1CH34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.2

Neutral momentum band

Price vs 200-day MA

-29.3%

50/200-day relationship not available

Beta (5Y)

1.41

More volatile than the market

Sharpe ratio

0.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/T1CH34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/T1CH34 stock rating?

bvmf/T1CH34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/T1CH34 analysis?

The full report lives at /stocks/bvmf/T1CH34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/T1CH34?

The latest report frames bvmf/T1CH34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/T1CH34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.